Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,300,372
+$6,972 QoQ
Shares Held
3,591
-2.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,524
of 3,140 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Berger Financial Group, Inc holds $30,167,656 across 8 Drug Manufacturers - General names. AMGN ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
39,841 | $10,118,418 | |
| 2 | LLY |
ELI LILLY & Co
|
6,514 | $7,813,087 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
46,072 | $5,820,736 | |
| 4 | ABBV |
AbbVie Inc.
|
14,283 | $3,594,174 | |
| 5 | AMGN |
Amgen Inc
This page
|
3,591 | $1,300,372 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,364 | $1,074,774 | |
| 7 | PFE |
Pfizer Inc
|
9,471 | $228,061 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,784 | $218,034 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,300,372 | 3,591 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,293,400 | 3,676 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,247,378 | 3,811 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,076,310 | 3,814 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,060,160 | 3,797 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,179,839 | 3,787 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,090,257 | 4,183 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,450,267 | 4,501 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,402,900 | 4,490 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,283,989 | 4,516 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,304,730 | 4,530 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,232,533 | 4,586 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,007,304 | 4,537 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,104,072 | 4,567 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,199,214 | 4,566 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,009,341 | 4,478 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,019,913 | 4,192 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,019,029 | 4,214 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $983,118 | 4,370 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $968,195 | 4,553 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,098,093 | 4,505 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,086,055 | 4,365 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,081,773 | 4,705 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||